Form 8-K - Current report:
SEC Accession No. 0001178913-25-003005
Filing Date
2025-08-20
Accepted
2025-08-20 16:53:33
Documents
87
Period of Report
2025-08-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk2533676.htm   iXBRL 8-K 46487
2 EXHIBIT 99.1 exhibit_99-1.htm   iXBRL EX-99.1 1454617
3 GRAPHIC image00006.jpg GRAPHIC 16772
  Complete submission text file 0001178913-25-003005.txt   9933921

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE slxn-20241231.xsd EX-101.SCH 152358
5 XBRL CALCULATION FILE slxn-20241231_cal.xml EX-101.CAL 43796
6 XBRL DEFINITION FILE slxn-20241231_def.xml EX-101.DEF 380197
7 XBRL LABEL FILE slxn-20241231_lab.xml EX-101.LAB 1443032
8 XBRL PRESENTATION FILE slxn-20241231_pre.xml EX-101.PRE 495000
90 EXTRACTED XBRL INSTANCE DOCUMENT zk2533676_htm.xml XML 1554652
Mailing Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606
Business Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606 972-8-6286005
Silexion Therapeutics Corp (Filer) CIK: 0002022416 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42253 | Film No.: 251237484
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)